Examkin

Question

Difficulty: HardDepressive Disorders

A 29-year-old woman presents to the clinic 4 weeks postpartum for a follow-up evaluation. She reports feeling profoundly sad, tearful, and unable to enjoy time with her newborn. She states, "I feel completely overwhelmed and guilty for being a terrible mother." She wakes up at 3:00 AM every day and is unable to fall back asleep, despite her husband handling the nighttime feedings. She has a poor appetite and has lost 4.5 kg (10 lb) since her delivery. She denies any thoughts of harming herself or her infant. She had an uncomplicated vaginal delivery but required a second-degree perineal laceration repair; she takes tramadol occasionally for residual pain. When reviewing her psychiatric history, she mentions that during her sophomore year of college, she experienced a distinct 5-day period where she felt "invincible," required only 2 hours of sleep per night, and started three different student organizations while speaking so rapidly her friends could hardly understand her. This college episode resolved spontaneously without hospitalization. Which of the following is the most appropriate next step in management?

  1. A
    Initiate sertraline
  2. B
    Initiate tranylcypromine
  3. Initiate quetiapineAnswer
  4. D
    Initiate bupropion
  5. E
    Reassure the patient that her symptoms are a physiologic consequence of the postpartum period

Answer

Initiate quetiapine
This patient is experiencing a major depressive episode (depressed mood, anhedonia, sleep disturbance, weight loss, severe guilt) with peripartum onset. Crucially, her history of a 5-day period of elevated mood, decreased need for sleep, pressured speech, and increased goal-directed activity without hospitalization meets the criteria for a hypomanic episode. Therefore, her correct diagnosis is Bipolar II disorder. In patients with bipolar depression, monotherapy with standard antidepressants (such as SSRIs) is contraindicated because it can precipitate a hypomanic or manic switch. First-line evidence-based treatments for bipolar depression include certain atypical antipsychotics (e.g., quetiapine, lurasidone, cariprazine) or mood stabilizers. Quetiapine is an excellent choice for this patient, as it treats bipolar depression effectively and is frequently used during the postpartum period due to its well-established safety profile.

Step-by-Step Solution

1
Evaluate the current mood episode based on the patient's presenting symptoms.
The patient presents with severe sadness, anhedonia, early morning awakening, weight loss, and guilt lasting 4 weeks postpartum, which meets the criteria for a major depressive episode with peripartum onset.
To establish the current clinical problem requiring intervention.
2
Analyze the patient's psychiatric history for prior mood episodes.
The patient describes a past 5-day episode of elevated mood, decreased need for sleep, increased goal-directed activity, and pressured speech that resolved without hospitalization, which meets the criteria for a hypomanic episode.
To differentiate between unipolar depression and bipolar depression, which fundamentally alters the treatment approach.
3
Synthesize the current and past history to determine the correct diagnosis.
A history of at least one hypomanic episode and at least one major depressive episode indicates a diagnosis of Bipolar II disorder.
To guide the selection of appropriate pharmacotherapy and avoid contraindicated agents.
4
Select the most appropriate pharmacotherapy for the patient's diagnosis.
First-line treatment for bipolar depression includes atypical antipsychotics such as quetiapine or lurasidone, which treat depression without the risk of inducing a manic switch.
To provide safe and effective management while avoiding contraindicated medications like antidepressant monotherapy.

Key Concept

Patients presenting with a major depressive episode must be carefully screened for a history of mania or hypomania. If a history is present (indicating bipolar disorder), antidepressant monotherapy is contraindicated due to the risk of mood switch, and treatments like quetiapine or lurasidone are preferred.
Estimated Time:1m 30s
Rate this question

Topics

Depressive Disorders

More questions from this topic